Logotype for Freightways Group Limited

Freightways Group (FRW) H1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Freightways Group Limited

H1 2025 earnings summary

16 Jun, 2026

Executive summary

  • Revenue grew 6.7% year-over-year to NZD 662.1 million, with EBITDA/EBITA up 6.5% to NZD 86 million and NPAT up 9.5% to NZD 44.7 million, despite challenging New Zealand market conditions.

  • Express Package & Business Mail and Information Management divisions delivered revenue and profit growth, with strong operational improvements and efficiency gains.

  • Market share gains and pricing improvements offset volume declines in New Zealand; Australia showed robust growth, especially in Allied Express.

  • Interim dividend increased to NZD 0.19 per share, up from NZD 0.18 in prior years, with a record date of 7 March 2025 and payment on 1 April 2025.

  • Disciplined capital management and ongoing M&A strategy, with investments in automation, infrastructure, and digital capabilities.

Financial highlights

  • Group operating revenue rose 6.7% to NZD 662.1 million; EBITA up 6.5% to NZD 86 million; NPAT up 9.5% to NZD 44.7 million.

  • Express Package & Business Mail revenue up 5.8% to NZD 547.2 million; EBITA up 12% to NZD 80 million; margin improved by 80bp to 14.6%.

  • Information Management & Waste Renewal revenue up 11.3% to NZD 117.6 million; EBITA flat at NZD 15.5 million due to one-off costs.

  • Net cash inflow from operations was NZD 76.3 million, up from NZD 58.3 million year-over-year.

  • Interim dividend declared at NZD 0.19 per share, totaling approximately NZD 34 million.

Outlook and guidance

  • Cautiously optimistic for New Zealand in H2, expecting slow organic growth; Australian market remains more buoyant.

  • Focus on restoring margins in FY25 and FY26 as organic growth and market share gains are realized.

  • Full-year CapEx guidance at NZD 35 million, focused on operational tools, IT, and mechanisation.

  • Project Evolve OpEx spend of NZD 5 million in FY25 and FY26, not included in CapEx.

  • Additional Medical Waste revenue delayed to Q4; anticipation of a significant Victorian contract.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more